Instem plc Director/PDMR Shareholding (0152O)
February 04 2016 - 2:00AM
UK Regulatory
TIDMINS
RNS Number : 0152O
Instem plc
04 February 2016
Instem plc
("Instem" or the "Company")
Director Shareholding
Instem (AIM: INS), a leading provider of IT solutions to the
global early development healthcare market, was notified yesterday
of the following deals in the ordinary shares of 10 pence each in
the Company ("Ordinary Shares") by David Gare, Chairman.
David Gare is a trustee of the 'The DG 2008 Discretionary
Settlement' (the "Trust") which on 3 February 2016 transferred
50,000 Ordinary Shares to each of two beneficiaries, Michael Adrian
Gare and Deborah Jane Walker, at nil cost (the "Transaction").
Following the Transaction, the notifiable interest of David Gare
is 2,018,427 Ordinary Shares, representing 15.5% of the Company's
issued Ordinary Shares. Such shares are all held by the Trust.
For further information, please contact:
Instem plc +44 (0) 1785 825 600
Phil Reason, CEO
Nigel Goldsmith, CFO
N+1 Singer (Nominated
Adviser & Broker) +44 (0) 20 7496 3000
Richard Lindley
James White
Walbrook Financial PR +44 (0) 20 7933 8000
Paul Cornelius instem@walbrookpr.com
Helen Cresswell
Sam Allen
About Instem plc
Instem is a leading supplier of IT applications to the early
development healthcare market, delivering compelling solutions for
data collection, management and analysis across the R&D
continuum. Instem applications are in use by customers worldwide,
meeting the rapidly expanding needs of life science and healthcare
organisations for data-driven decision making leading to safer,
more effective products.
Instem's portfolio of software solutions increases client
productivity by automating study-related processes while offering
the unique ability to generate new knowledge through the extraction
and harmonisation of actionable scientific information.
Instem supports over 400 clients through full service offices in
the United States, the United Kingdom, India and China, with
additional presence in France and Japan.
To learn more about Instem solutions and its mission, please
visit www.instem.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSBCGDDCDGBGLX
(END) Dow Jones Newswires
February 04, 2016 02:00 ET (07:00 GMT)
Instem (LSE:INS)
Historical Stock Chart
From Jul 2024 to Aug 2024
Instem (LSE:INS)
Historical Stock Chart
From Aug 2023 to Aug 2024